Back
ESC Premium Access

Transradial vs. transfemoral access in patients with ACS: bleeding complications and outcome

Session: Coronary revascularisation: how and how much
Topic: Infarction acute phase STEMI
Speaker: Doctor J. Roehnisch (Berlin, DE)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Jens-Uwe Roehnisch

Vivantes Clinics for Health, Berlin (Germany)
0 follower

6 more presentations in this session

Routine invasive versus selective invasive strategies for non-st-elevation acute coronary syndrome: an updated meta-analysis of randomised trials

Speaker: Associate Professor A. Bavry (Gainesville, US)

Access
Abstract
Slides
Thumbnail

Differential impact of incomplete revascularization as assessed by residual SYNTAX score on long-term mortality in patients with STEMI versus NSTEMI: a propensity-matched analysis

Speaker: Doctor D. Milasinovic (Belgrade, RS)

Access
Abstract
Slides
Thumbnail

Complete or incomplete coronary revascularization in ACS patients with multivessel coronary disease. One year outcomes according to clinical presentation from the real life Bleemacs registry

Speaker: Doctor C. Moretti (Chivasso, IT)

Access
Abstract
Slides
Thumbnail

Culprit vessel-only vs. multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease: results from an 8-year prospective registry

Speaker: Doctor R. GONZALEZ FERREIRO (Vigo, ES)

Access
Abstract
Thumbnail

Impact of staged versus one-time multivessel percutaneous ntervention in ST-elevation myocardial infarction

Speaker: Doctor M. Makkiya (The Bronx, US)

Access
Abstract
Slides
Thumbnail

Access the full session

Coronary revascularisation: how and how much

Speakers: Doctor J. Roehnisch, Associate Professor A. Bavry, Doctor D. Milasinovic, Doctor C. Moretti, Doctor R. GONZALEZ FERREIRO...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb